Webster Lindsay, Rider Nicholas L, Archambault Mark E
Lindsay Webster practices at Novant Health-Wallburg Family Medicine in Winston-Salem, N.C. Nicholas L. Rider is an associate professor of pediatrics at Baylor College of Medicine, Texas Children's Hospital, in Houston, Tex. Mark E. Archambault is an associate professor in the doctor of medical science program, physician assistant education concentration, at Lynchburg (Va.) College. The authors have disclosed no potential conflicts of interest, financial or otherwise.
JAAPA. 2018 Jul;31(7):22-26. doi: 10.1097/01.JAA.0000534976.46365.11.
Chronic idiopathic urticaria (CIU), also known as chronic spontaneous urticaria, is characterized by the presence of hives on most days of the week, for 6 weeks or longer, and without an identifiable or consistent cause. Evaluation is clinical and based on the presence of episodic urticarial lesions. Although patients are subject to overtesting during the diagnosis of CIU, guidelines suggest starting with three basic laboratory tests. Treatment is a stepwise approach, involving second-generation antihistamines, histamine2 antagonists, leukotriene receptor antagonists, first-generation antihistamines, and potent antihistamines. Refractory CIU requires adding alternative agents such as omalizumab, anti-inflammatory agents, and immunosuppressants.
慢性特发性荨麻疹(CIU),也称为慢性自发性荨麻疹,其特征是一周中大多数日子出现荨麻疹,持续6周或更长时间,且无明确或一致的病因。诊断基于临床症状及间歇性荨麻疹皮损的存在。尽管在CIU诊断过程中患者可能会接受过多检查,但指南建议首先进行三项基本实验室检查。治疗采用逐步治疗方法,包括使用第二代抗组胺药、组胺2拮抗剂、白三烯受体拮抗剂、第一代抗组胺药和强效抗组胺药。难治性CIU需要加用其他药物,如奥马珠单抗、抗炎药和免疫抑制剂。